author_facet Aggarwal, Rahul Raj
Thomas, Scott
Grabowsky, Jennifer A.
Harb, Armand
Leng, Jim
Reinert, Anne
Mastroserio, Ilaria
Truong, Thach-Giao
Munster, Pamela N.
Aggarwal, Rahul Raj
Thomas, Scott
Grabowsky, Jennifer A.
Harb, Armand
Leng, Jim
Reinert, Anne
Mastroserio, Ilaria
Truong, Thach-Giao
Munster, Pamela N.
author Aggarwal, Rahul Raj
Thomas, Scott
Grabowsky, Jennifer A.
Harb, Armand
Leng, Jim
Reinert, Anne
Mastroserio, Ilaria
Truong, Thach-Giao
Munster, Pamela N.
spellingShingle Aggarwal, Rahul Raj
Thomas, Scott
Grabowsky, Jennifer A.
Harb, Armand
Leng, Jim
Reinert, Anne
Mastroserio, Ilaria
Truong, Thach-Giao
Munster, Pamela N.
Journal of Clinical Oncology
Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
Cancer Research
Oncology
author_sort aggarwal, rahul raj
spelling Aggarwal, Rahul Raj Thomas, Scott Grabowsky, Jennifer A. Harb, Armand Leng, Jim Reinert, Anne Mastroserio, Ilaria Truong, Thach-Giao Munster, Pamela N. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2016.34.15_suppl.2519 Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies. Journal of Clinical Oncology
doi_str_mv 10.1200/jco.2016.34.15_suppl.2519
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNi4zNC4xNV9zdXBwbC4yNTE5
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNi4zNC4xNV9zdXBwbC4yNTE5
institution DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
imprint American Society of Clinical Oncology (ASCO), 2016
imprint_str_mv American Society of Clinical Oncology (ASCO), 2016
issn 0732-183X
1527-7755
issn_str_mv 0732-183X
1527-7755
language English
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
match_str aggarwal2016abexinostatabxasameanstoreversepazopanibpazresistanceaphase1studyinadvancedsolidtumormalignancies
publishDateSort 2016
publisher American Society of Clinical Oncology (ASCO)
recordtype ai
record_format ai
series Journal of Clinical Oncology
source_id 49
title Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
title_unstemmed Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
title_full Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
title_fullStr Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
title_full_unstemmed Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
title_short Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
title_sort abexinostat (abx) as a means to reverse pazopanib (paz) resistance: a phase 1 study in advanced solid tumor malignancies.
topic Cancer Research
Oncology
url http://dx.doi.org/10.1200/jco.2016.34.15_suppl.2519
publishDate 2016
physical 2519-2519
description
container_issue 15_suppl
container_start_page 2519
container_title Journal of Clinical Oncology
container_volume 34
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792323558307790865
geogr_code not assigned
last_indexed 2024-03-01T11:35:14.141Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Abexinostat+%28ABX%29+as+a+means+to+reverse+pazopanib+%28PAZ%29+resistance%3A+A+phase+1+study+in+advanced+solid+tumor+malignancies.&rft.date=2016-05-20&genre=article&issn=1527-7755&volume=34&issue=15_suppl&spage=2519&epage=2519&pages=2519-2519&jtitle=Journal+of+Clinical+Oncology&atitle=Abexinostat+%28ABX%29+as+a+means+to+reverse+pazopanib+%28PAZ%29+resistance%3A+A+phase+1+study+in+advanced+solid+tumor+malignancies.&aulast=Munster&aufirst=Pamela+N.&rft_id=info%3Adoi%2F10.1200%2Fjco.2016.34.15_suppl.2519&rft.language%5B0%5D=eng
SOLR
_version_ 1792323558307790865
author Aggarwal, Rahul Raj, Thomas, Scott, Grabowsky, Jennifer A., Harb, Armand, Leng, Jim, Reinert, Anne, Mastroserio, Ilaria, Truong, Thach-Giao, Munster, Pamela N.
author_facet Aggarwal, Rahul Raj, Thomas, Scott, Grabowsky, Jennifer A., Harb, Armand, Leng, Jim, Reinert, Anne, Mastroserio, Ilaria, Truong, Thach-Giao, Munster, Pamela N., Aggarwal, Rahul Raj, Thomas, Scott, Grabowsky, Jennifer A., Harb, Armand, Leng, Jim, Reinert, Anne, Mastroserio, Ilaria, Truong, Thach-Giao, Munster, Pamela N.
author_sort aggarwal, rahul raj
container_issue 15_suppl
container_start_page 2519
container_title Journal of Clinical Oncology
container_volume 34
description
doi_str_mv 10.1200/jco.2016.34.15_suppl.2519
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNi4zNC4xNV9zdXBwbC4yNTE5
imprint American Society of Clinical Oncology (ASCO), 2016
imprint_str_mv American Society of Clinical Oncology (ASCO), 2016
institution DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15
issn 0732-183X, 1527-7755
issn_str_mv 0732-183X, 1527-7755
language English
last_indexed 2024-03-01T11:35:14.141Z
match_str aggarwal2016abexinostatabxasameanstoreversepazopanibpazresistanceaphase1studyinadvancedsolidtumormalignancies
mega_collection American Society of Clinical Oncology (ASCO) (CrossRef)
physical 2519-2519
publishDate 2016
publishDateSort 2016
publisher American Society of Clinical Oncology (ASCO)
record_format ai
recordtype ai
series Journal of Clinical Oncology
source_id 49
spelling Aggarwal, Rahul Raj Thomas, Scott Grabowsky, Jennifer A. Harb, Armand Leng, Jim Reinert, Anne Mastroserio, Ilaria Truong, Thach-Giao Munster, Pamela N. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2016.34.15_suppl.2519 Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies. Journal of Clinical Oncology
spellingShingle Aggarwal, Rahul Raj, Thomas, Scott, Grabowsky, Jennifer A., Harb, Armand, Leng, Jim, Reinert, Anne, Mastroserio, Ilaria, Truong, Thach-Giao, Munster, Pamela N., Journal of Clinical Oncology, Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies., Cancer Research, Oncology
title Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
title_full Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
title_fullStr Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
title_full_unstemmed Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
title_short Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
title_sort abexinostat (abx) as a means to reverse pazopanib (paz) resistance: a phase 1 study in advanced solid tumor malignancies.
title_unstemmed Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: A phase 1 study in advanced solid tumor malignancies.
topic Cancer Research, Oncology
url http://dx.doi.org/10.1200/jco.2016.34.15_suppl.2519